


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
URGN
UroGen Pharma Ltd.
$21.80
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
URGN Price Performance
$23.7 (-8.02%)
$17.95 (+21.45%)
$18 (+21.11%)
$10.76 (+102.60%)
URGN has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

URGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
URGN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
URGN Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is URGN current stock price?
What are URGN stock strengths?
What is URGN Risk Level?
What is URGN market cap and volume?
What is URGN current Stock IQ?
Should I buy URGN stock right now?
Is URGN a Strong Buy right now?
What does a 'Strong Buy' rating mean for URGN?
What does a 'Strong Sell' rating mean for URGN?
What factors influence URGN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.48%
+0.64%
-1.40%
-3.21%
-6.46%
URGN
UroGen Pharma Ltd.
Current Price
$21.80
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

URGN Price Performance
$23.7 (-8.02%)
$17.95 (+21.45%)
$18 (+21.11%)
$10.76 (+102.60%)
URGN Analysts Opinion
URGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
URGN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
URGN Street Sentiment is extremely bullish and have negative views on the near-term outlook
URGN has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
URGN Stock IQ
URGN Latest Analysis
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). PRINCETON N.J. Dec. 05 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN) a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers today announced the grants of inducement restricted stock units (RSUs) to 14 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Je
Fri Dec 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
URGN Stock trends
URGN Stock performance
URGN Stock analysis
URGN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.